(Reuters) - Roche said the $75 per share tender offer would expire on August 23, instead of July 25 as previously scheduled. All other terms of the tender offer remained the same.
Earlier in July, Ventana rejected Roche's offer, saying the bid undervalued the company and its prospects in the fast-growing cancer-testing market. Roche launched the tender offer on June 27.
Read more at Reuters.com Mergers News
Earlier in July, Ventana rejected Roche's offer, saying the bid undervalued the company and its prospects in the fast-growing cancer-testing market. Roche launched the tender offer on June 27.
Read more at Reuters.com Mergers News
No comments:
Post a Comment